Found 7 matching trials
A Heterologous Prime-boost Study to Evaluate Immunogenicity and Safety of mRNA-1273 With MVC-COV1901 in Adults
PHASE4The primary objective of the study is to evaluable the safety and to demons...
Location
National Taiwan University Hospital
Immunogenicity of Heterologous Versus Homologous Prime Boost Schedule With mRNA and Inactivated COVID-19 Vaccines
PHASE3This study is a randomized, simple-blinded comparative phase III clinical t...
Location
Leoni factory (Governorate of Bizerte)
2013/2017 H7N9 Prime-Boost Interval
PHASE2This is a trial designed to assess the safety, reactogenicity and immunogen...
Location
Emory Children's Center - Pediatric Infectious Diseases
Immunogenicity and Safety of 2 Schedules of ALVAC-HIV vCP1452 in Chronically HIV-Infected Patients
PHASE2Prior pilot studies have shown that four monthly injections of ALVAC-HIV (v...
Location
Northwestern University Medical School
Immunogenicity and Safety of Heterologous and Homologous Boosting With ChAdOx1-S and CoronaVac or a Formulation of SCB-2019 (COVID-19)
PHASE2SARS-CoV-2 is a highly transmissible and pathogenic coronavirus that emerge...
Location
Hospital de Clínicas de Porto Alegre
Immunogenicity of COVID-19 Vaccine on Heterologous Schedule
PHASE2This is a prospective, single blinded randomized homologous/heterologous pr...
A Safety and Immunogenicity Study of Heterologous and Homologous Prime-Boost Ebola Vaccine Regimens in Healthy Participants
PHASE1The purpose of this study is to test the safety and immunogenicity of MVA-B...
Location
Multiple Locations